| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aligos Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 5,860 | 25 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ALGS | Aligos Therapeutics, Inc. | 25 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 16:29 |
| ALGS | Aligos Therapeutics, Inc. | 07 Aug 2024 | 1 | $0 | 4 | Director | 09 Aug 2024, 16:09 |
| ALGS | Aligos Therapeutics, Inc. | 07 Aug 2024 | 0 | $0 | 3 | Director | 09 Aug 2024, 16:08 |